Robert Edward Walker
CIK: 0002127840
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVAX
NOVAVAX INC
Officer
Discretionary Trading P&L
Holdings
About Walker Robert Edward
Walker Robert Edward (SEC CIK 0002127840) files insider reports with the SEC as EVP, R&D of NOVAVAX INC (NVAX).
Signal8 holds 2 ownership filings by Walker Robert Edward (1 Form 3, 1 Form 4), filed on Apr 16, 2026. Those filings report 2 transactions, the latest on Apr 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Walker Robert Edward's filings is in GAITHERSBURG, MD.
Recent filings by Walker Robert Edward
- Apr 14, 2026: Grants or awards of NVAX derivative securities (2 lines, Form 4, code A).
Other insiders filing for NOVAVAX INC (NVAX)
- Rodgers Richard J, Director
- King Rachel K., Director
- DOUGLAS RICHARD, Director
- MCGLYNN MARGARET G, Director
- MOTT DAVID M, Director
- Alton Gregg H, Director